- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
B
BNTX
BIONTECH
87.46
-1.31-1.48%Pre Market: 87.40 -0.06 -0.07%06:38 03/27 EDT
OPEN/PREV CLOSE87.89/88.77
TODAY RANGE87.18-89.34
VOL3
MARKET CAP21.98B
52 WEEK RANGE79.52-124.00
AVG VOL (3M)1.16M
% TURNOVER0.27%
TURNOVER56.93M
P/E (TTM)-15.8528
% RANGE2.43%
EPS(TTM)-5.5170
P/E(FORWARD)-18.5943
P/B0.9742
BVPS89.78
DIVIDEND--
P/S6.53
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.12B
SHARES OUTSTANDING251.33M
NEXT EARNINGS--
FREE FLOAT104.27M
LOT SIZE1
EX-DATE06/02/2022
News
Press Releases
Financial Reports
Profile
Simply Wall St·1h ago
BioNTech (NasdaqGS:BNTX) Valuation Check After New Lung Cancer Data Highlights Oncology Pipeline Progress
Seeking Alpha·1d ago
White House misses deadline for CDC director nominee
Simply Wall St·1d ago
BioNTech Lung Cancer Data Broadens Oncology Story Beyond Infectious Diseases
Seeking Alpha·5d ago
Trump administration reportedly shortlisting CDC nominees
TipRanks·03/16 22:45
District court rules federal limits to vaccines not based on science, NYT says
Barron‘s·03/16 21:13
BioNTech Stock Is a Bargain. Why Its Recent Selloff Is a Buying Opportunity.
Barron‘s·03/16 20:03
Covid Vaccine Maker BioNTech Offers Cheap Biotech Play Given Huge Cash Reserves
Simply Wall St·03/15 07:20
Why BioNTech (BNTX) Is Down 10.2% After Founders Announce Spinout And mRNA Asset Transfer
Simply Wall St·03/14 03:38
Assessing BioNTech (NasdaqGS:BNTX) Valuation After Founders’ Planned Exit And Weakening COVID-19 Revenues
Simply Wall St·03/13 00:39
Is It Time To Reconsider BioNTech (BNTX) After Its Recent Share Price Weakness?
Seeking Alpha·03/11 19:24
Moderna, BioNTech rise as vaccine advisory panel backs off mRNA vaccine threat
Same Industry
Name/Symbol
Change%
Price